Variant report
Variant | esv3412338 |
---|---|
Chromosome Location | chr20:1689620-1689920 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | SPI1 | chr20:1689259-1689736 | HL-60 | blood: | n/a | chr20:1689487-1689494 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SIRPB3P | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2077100 | chr20:1689621-1689622 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs5839916 | chr20:1689633-1689634 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs566134122 | chr20:1689634-1689635 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs2317999 | chr20:1689636-1689637 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs2318000 | chr20:1689639-1689640 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs2318001 | chr20:1689640-1689641 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs199662832 | chr20:1689641-1689642 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs538808547 | chr20:1689663-1689664 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs553648652 | chr20:1689679-1689680 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs386811644 | chr20:1689766-1689767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs588555 | chr20:1689767-1689768 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs554910393 | chr20:1689777-1689778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6111083 | chr20:1689802-1689803 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35061984 | chr20:1689827-1689828 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576494436 | chr20:1689856-1689857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544110 | chr20:1689858-1689859 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs138109426 | chr20:1689859-1689860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142599236 | chr20:1689869-1689870 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2318003 | chr20:1689872-1689873 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs735994 | chr20:1689898-1689899 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs530241770 | chr20:1689905-1689906 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190973342 | chr20:1689916-1689917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17603634 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 17363583 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:1688200-1689800 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
2 | chr20:1688200-1689800 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
3 | chr20:1688200-1689800 | Enhancers | Primary T helper cells fromperipheralblood | blood |
4 | chr20:1688200-1690000 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
5 | chr20:1688200-1690000 | Enhancers | Fetal Thymus | thymus |
6 | chr20:1688200-1690200 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr20:1688200-1690200 | Enhancers | Thymus | Thymus |
8 | chr20:1688800-1693000 | Weak transcription | HMEC | breast |
9 | chr20:1689200-1690200 | Enhancers | Primary T cells from cord blood | blood |
10 | chr20:1689400-1698200 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
11 | chr20:1689600-1693000 | Weak transcription | K562 | blood |